In physician-administered settings oncology clinics, infusion centers, rheumatology practices biosimilar adoption has been faster because physicians and oncology group practices make purchasing decisions based on acquisition cost (which directly affects their economic margin under the buy-and-bill model) rather than PBM formulary dynamics
The entire process typically takes 10 to 15 years and costs $1 billion or more
Have bland, easily digestible foods available in case you can eat small amounts
Melittin: from honeybees to superbugs
Therefore, the information pharmacist team of our hospital pays close attention to the new drug dynamics of GLP-1RA drugs, the information of post-marketing re-evaluation of drugs, pharmacological properties, clinical application, occurrence of adverse reactions, etc
This precision makes it ideal for both research applications and potential clinical exploration